LNSR LENSAR, Inc.

6.700USD+0.45%Mkt Cap: 82.32M $P/E: 37.22

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astig…

Key Statistics

Company
Market Cap82.32M USD
Enterprise Value84.92M USD
Revenue (TTM)60.26M USD
Gross Profit27.12M USD
Net Income (TTM)-34.28M USD
Revenue/Share4.96 USD
Last Price6.700 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)37.22
P/E (Forward)-13.14
PEG—
EV/EBITDA-5.20
EV/Revenue1.41
P/S1.37
P/B5.52
EPS (TTM)0.18
EPS (Forward)-0.51
52W Range
4.95022% of range12.94
52W High12.94 USD
52W Low4.950 USD
Profitability
Gross Margin46.41%
Oper. Margin12.94%
EBITDA Margin-27.09%
Profit Margin-58.66%
ROE131.75%
ROA-47.99%
Growth
Revenue Growth18.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.83M USD
CapEx (TTM)83.00K USD
FCF Margin-40.47%
FCF Yield-29.63%
Net Debt-11.18M USD
Net Debt/EBITDA0.68
Balance Sheet
Debt/Equity-0.11
Current Ratio2.39
Quick Ratio1.03
Book Value/Sh1.21 USD
Cash/Share1.10 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.33 USD
Upside (mean)+69.2%
Target Range10.00 USD – 13.00 USD
10.00+69.2% to mean13.00
# Analysts3
Ownership
Shares Out.12.29M
Float8.84M
Insiders21.52%
Institutions45.97%
Short Interest
Short Ratio3.2d
Short % Float3.81%
Short % Out.2.75%
Shares Short338.23K
Short (prev mo.)415.43K
Technical
SMA 507.252 (-7.6%)
SMA 2007.992 (-16.2%)
Beta0.95
S&P 52W Chg16.45%
Avg Vol (30d)82.43K
Avg Vol (10d)35.64K
Technical Indicators
RSI (14)40.6
MACD-0.1998
MACD Signal-0.0820
MACD Hist.-0.1177
BB Upper8.621 USD
BB Middle7.316 USD
BB Lower6.012 USD
BB Width35.66%
ATR (14)0.3309 USD
Vol Ratio (20d)0.53x